ReviewCancers2022

Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?

Emile Verhulst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.